36.6 F
New York
Wednesday, January 27, 2021

Pfizer [NYSE: PFE], BioNTech [NASDAQ: BNTX] To Receive $1.9b Billion For Millions Coronavirus Vaccine Doses

Must read

Humanigen [NASDAQ: HGEN] Announces Expansion Of Manufacturing Agreement With Ajinomoto Bio-Pharma

Humanigen Inc revealed that the company has extended the manufacturing agreement with  Ajinomoto BioPharma to support the fill-finish of Lenzilumab. The Lenzilumab is...

Synchrony [NYSE: SYF] Announced To Purchase Allegro Credit

Synchrony Financials revealed that the company entered into a definitive contract to Purchase Allegro Credit. Allegro Credit's customer base and merchant network will...

Vericel Corp [NASDAQ: VCEL] Names Joe Mara As The New CFO

Vericel Corporation revealed that the company has named Joe Mara as the CFO of the company. He has over more than 20 years...

A Paychex [NASDAQ: PAYX] Subsidiary Announces Strategic Collaboration With Zoho Books

SurePayroll, a subsidiary of Paychex company revealed that the company has formed a collaboration with Zoho books. SurePAyroll is a provider of small...

Pfizer Inc. [NYSE: PFE] and BioNTech [NASDAQ: BNTX] have got the initial order form the US government for the 100 million doses of COVID-19 vaccine and can gain additional order of 500 million doses after approval. Both the companies are jointly developing the coronavirus vaccine.

US Department of Health and Human Services and the Department of Defense has agreed to pay $1.95 billion to Pfizer for the production and delivery of 100 million doses in the US if it proves safe and effective in humans. According to both companies, Americans will receive coronavirus vaccines for free.

Pfizer has exhibited a change of 0.52% and up +0.19 during the trading of Tuesday. It has a closing price of $36.69. In the past 52-weeks of trading, it has recorded the low and high range of $27.88-$43.23, respectively.

This company had a trading volume of 22.44 million as compared to the average volume of 28.87 million. It has total market capitalization of 200.15 billion. Right now, this company has Gross Margin of 80.40%, Profit Margin of 31.20%, and an Operating Margin of 32.10%.

BioNTech SE has total market capitalization of 18.64 billion. In the past 52-weeks of trading, it has fluctuated between the low and high of $12.52-$105.00, respectively. It has gross margin of 88.30% and return on investment of -31.40%.

Dr. Albert Bourla, Pfizer Chairman and CEO said that the company is working tirelessly to develop the vaccine to put an end to this pandemic. He disclosed that the company has made a decision to started working on the vaccine on its own risk and started the production in large scale if clinical trials prove successful.

BNT162 is not fully approved for the dstribution across the world and are undergoing clinical studies. Pfizer and BioNTech both are striving to make the vaccines for the novel coronavirus. Earlier, the company’s four investigational candiates (BNT162b1) and (BNT162b2) has got fast track designation from the US Food and Drug Authority.

Pfizer and BioNTech are on track to launch Phase 2b/3, safety and efficacy test by the end of this month, and expected to seek regulatory review as early as October 2020. The company will produce 100 million doses globally by the end of 2020 and possibly more than 1.3 billion doses by the end of 2021.

More articles

Latest article

MGP Ingredients [NASDAQ: MGPI] Announced To Acquire Luxco and Its Affiliate Companies

MGP Ingredients  revealed a definitive contract to purchase Luxco, Inc and its affiliated companies. Luxco is an alcohol beverage company with more than 60...

Conformis [NASDAQ: CFMS] Entered A Non-Exclusive agreement with SITES Medical

Conformis Inc revealed that the company inked a development and supply contract with sites medical. Both of the companies will work together to...

Colliers International [NASDAQ: CIGI] Announces Executive Leadership Changes For Australian Business

Colliers International  reported that the company has named Malcom Tyson as the new Chief Executive Officer. He is appointed as the CEO so...

Korn Ferry [NYSE: KFY] Announces Expansion Of Its Footprint In Russian Market

Korn Fery revealed that the company is expanding its footprint in Russia. Moreover, it is adding a high expertise team of executive search...

Haemonetics [NYSE: HAE] To Purchase Cardiva For An Upfront Payment Of $475M

Haemonetics Corporation revealed that the company has inked a definitive contract to purchase Cardiva Medical Inc. Under the contract, Haemontics will pay an...

Philips [NYSE: PHG] To Purchase Capsule Technologies For Cash Consideration Of USD 635M

Koninklijke Philip revealed that the company has inked a contract to purchase Capsule technologies. The company will pay a cash price of $636...

Thermo Fisher Scientific [NYSE: TMO] To Purchase Mesa Biotech For Approx. $450M In Cash

Thermo fisher scientific inc revealed that the company has signed a definitive contract to purchase Mesa Biotech. Thermo will pay a value price...

Shutterstock [NYSE: SSTK] To Extend Its Agreement With EPA

Shutterstock reported that the company renewed its exclusive contract with the European Pressphoto Agency. The extended contract is to distribute the visual content...